MedPath

Penicillin De-labeling in the Pediatric Primary Care Setting

Phase 4
Completed
Conditions
Penicillin Allergy
Penicillin Reaction
Interventions
Registration Number
NCT05010304
Lead Sponsor
University of Texas Southwestern Medical Center
Brief Summary

While reported adverse reactions to penicillins are common, most patients with a penicillin allergy label can safely tolerate penicillins, and elective evaluation for penicillin allergy has been recommended. For low-risk patients, direct oral challenge may be an optimal approach as a delabeling strategy. However, there is a vast disparity between the number of patients with a penicillin allergy label and practicing allergists in the United States, and implementing outpatient primary care-based delabeling strategies in low-risk patients may increase access to delabeling assessments. However, a recent survey of pediatricians identified perceived barriers to implementing penicillin allergy evaluations into their routine care. Significant gaps in knowledge exist regarding the feasibility of this approach involving risk stratification evaluation of reported penicillin adverse reactions and direct amoxicillin challenge procedures in low-risk patients in the pediatric primary care setting. With this, the primary aim of this study is to evaluate the number of patients for which risk-stratification and direct amoxicillin challenge are successfully completed in an outpatient pediatric primary care clinic.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
23
Inclusion Criteria
  • Children from ages 2-18 years with a history of parent-reported penicillin allergy.
Exclusion Criteria
  • Children with a history of reaction consistent with a severe cutaneous adverse reaction to penicillin as defined as a history of oral blisters, diffuse skin peeling or blisters after taking a penicillin, or having the diagnosis of Stevens Johnson Syndrome, Toxic Epidermal Necrolysis, Drug rash with eosinophilia and systemic symptoms will be excluded. Pregnant and breastfeeding female subjects will be excluded

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Pediatric Patients with a history of penicillin allergyAmoxicillin-
Primary Outcome Measures
NameTimeMethod
Subjects Stratified as Low-risk With a Negative Immediate Amoxicillin Challenge in the Pediatric Primary Care SettingDay 1
Subjects Who Complete Risk-stratification of Penicillin Allergy in the Pediatric Primary Care SettingDay 1
Secondary Outcome Measures
NameTimeMethod
Penicillin Allergy Labeling in Subjects With Negative Amoxicillin Challenge10-14 months after amoxicillin challenge

Subjects who have a penicillin allergy label added back to their electronic health record at 10-14 months after amoxicillin challenge.

Trial Locations

Locations (1)

Children's Medical Center Dallas

🇺🇸

Dallas, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath